South African Medical News

Back to Home Page

Print using browser
Dozra 300 mg Tablets - Zidovudine (Novagen)


novagenpharmanewlogo







Dear Healthcare Professional

Novagen Pharma would like to inform you that with immediate effect the sale and distribution of Dozra 300 mg Tablets in the South African private sector is hereby discontinued.

This action is not the result of any safety or efficacy issues regarding this product.

If you have any further queries, please contact your local representative or Novagen Pharma on 08600NOVAG.

Novagen Pharma sincerely apologise for any inconvenience they may have caused and assure you of their commitment to quality service excellence at all times.
  • This is a drug - read the leaflet carefully before use 
  • Ask your doctor or pharmacist for further information.

FOR FULL PRESCRIBING INFORMATION REFER TO THE PACKAGE INSERT APPROVED BY THE MEDICINES REGULATORY AUTHORITY.

Marketed by: Novagen Pharma (Pty) Ltd. Reg No: 2008/026436/07. 100 Sovereign Drive, Route 21 Corporate Park, Nellmapius Road, Irene, Pretoria, South Africa.  

You need to be logged in to see more details. Register Now!


Click here to visit the Novagen Pharma website...
Contact: Shirley Holmes, Specialised Account Manager
Telephone: +27 (0) 12 345 3175
E-mail: shirley@novagenpharma.co.za
Date: Thursday, January 17, 2019